Connect the Dots

Work

Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018

Study in JAMA Internal Medicine, 2020, using OpenSecrets and campaign-finance data.

1 link, 0 backed by primary records

Explore connections

Dates
2020

Connections 1

author

Timeline 2 dates
  1. 2020 Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018
  2. 2020 Olivier J. Wouters authored Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018
Proof 1 source
  1. Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018, JAMA Internal Medicine, 2020. Scholarship & press
    Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018
    recorded $4.7 billion—an average of $233 million per year—in lobbying expenditures at the federal level, more than any other industry.
    Expenditures peaked at $318 million in 2009, the year before the Patient Protection and Affordable Care Act was signed into law.
    accounted for $422 million (9.0%)
Page history 1 change
  1. Add 55 stories, each checked against its sourcesAlibek96e92fe6

Something wrong or missing? Tell us, with a source, or edit this page.